Example: Heart Attack

Clinical Trials on Muscular Dystrophies, Limb-Girdle

Total 36 results

    • NCT01783509
      Completed
      Limb Girdle Muscular Dystrophy (LGMD) Natural History
      Conditions: Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
    • NCT02245711
      Withdrawn
      Cell Therapy in Limb Girdle Muscular Dystrophy
      Conditions: Limb Girdle Muscular Dystrophy
    • NCT03492346
      Recruiting
      Limb Girdle Muscular Dystrophy Type 2E Recruitment Study
      Conditions: Limb-Girdle Muscular Dystrophy, Type 2E
    • NCT03783923
      Active, not recruiting
      A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
      Conditions: Limb-Girdle Muscular Dystrophy
    • NCT02050776
      Withdrawn
      Stem Cell Therapy in Limb Girdle Muscular Dystrophy
      Conditions: Limb Girdle Muscular Dystrophy
    • NCT03488784
      Recruiting
      Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E
      Conditions: Limb-Girdle Muscular Dystrophy Type 2A; Limb-Girdle Muscular Dystrophy, Type 2E
    • NCT00457912
      Completed
      Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
      Conditions: Limb-Girdle Muscular Dystrophy
    • NCT03930628
      Recruiting
      Limb-Girdle Muscular Dystrophy Type 2I in Norway
      Conditions: Limb Girdle Muscular Dystrophy, Type 2I; Limb Girdle Muscular Dystrophy; Muscular Dystrophies
    • NCT01344798
      Completed
      Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
      Conditions: Limb Girdle Muscular Dystrophy Type 2C; Gamma-sarcoglycanopathy
    • NCT02165358
      Completed
      Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
      Conditions: Becker Muscular Dystrophy; Limb-Girdle Muscular Dystrophy Type 2I
    • NCT03981289
      Enrolling by invitation
      Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
      Conditions: Limb Girdle Muscular Dystrophy; Muscular Dystrophies
    • NCT04475926
      Recruiting
      A Study of the Natural History of Patients With LGMD2E, LGMD2D, and LGMD2C, ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
      Conditions: Limb-girdle Muscular Dystrophy
    • NCT00893334
      Completed
      Evaluation of Limb-Girdle Muscular Dystrophy
      Conditions: Becker Muscular Dystrophy; Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency); Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency); Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
    • NCT02635321
      Completed
      MRI and Muscle Involvement in Patients With Mutations in GMPPB
      Conditions: Limb-girdle Muscular Dystrophy
    • NCT02759302
      Completed
      MRI on Persons With Mutations in POMT2 Gene (LGMD2N)
      Conditions: Limb-girdle Muscular Dystrophy
    • NCT03652259
      Active, not recruiting
      Gene Delivery Clinical Trial of SRP-9003 for Patients With LGMD2E (Beta-sarcoglycan Deficiency)
      Conditions: Limb-Girdle Muscular Dystrophy, Type 2E
    • NCT03842878
      Recruiting
      Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I
      Conditions: LGMD2I
    • NCT04202627
      Enrolling by invitation
      Biomarker Development in LGMD 2i
      Conditions: Muscular Dystrophies; Limb Girdle Muscular Dystrophy
    • NCT01976091
      Completed
      Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA
      Conditions: Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
    • NCT00494195
      Completed
      Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
      Conditions: Muscular Dystrophies
    • NCT02579239
      Completed
      The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
      Conditions: Limb-Girdle Muscular Dystrophies; Facioscapulohumeral Muscular Dystrophy
    • NCT02836418
      Completed
      Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
      Conditions: Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular Dystrophy
    • NCT04054375
      Active, not recruiting
      Weekly Steroids in Muscular Dystrophy
      Conditions: Limb-girdle Muscular Dystrophy; Becker Muscular Dystrophy
    • NCT01126697
      Completed
      Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
      Conditions: Duchenne Muscular Dystrophy; Becker Muscular Dystrophy; Limb Girdle Muscular Dystrophy
    • NCT01066455
      Completed
      Cardiac Outcome Measures in Children With Muscular Dystrophy
      Conditions: Duchenne Muscular Dystrophy; Becker Muscular Dystrophy; Limb Girdle Muscular Dystrophy
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations